Cardiovascular System Practice Questions

Q: All of the following peptides produce vasodilation in most vascular beds EXCEPT?

Endothelin. **Explanation:** The correct answer is **Endothelin (Option A)**. **1. Why Endothelin is the correct answer:** Endothelin-1 (ET-1) is the most potent endogenous **vasoconstrictor** known [1]. It acts primarily on **$ET_A$ receptors** located on vascular smooth muscle cells, leading to profound and sustained vasoconstriction [2]. While it can cause transient vasodilation via $ET_B$ receptors on endothelial cells (releasing NO), its dominant physiological effect in most vascular beds is intense constriction [2]. **2. Analysis of Incorrect Options:** * **Bradykinin (Option B):** A potent vasodilator that acts by stimulating the release of Nitric Oxide (NO) and Prostacyclin ($PGI_2$). It also increases capillary permeability. * **Vasoactive Intestinal Peptide (VIP) (Option C):** A neurotransmitter/hormone that induces systemic vasodilation and lowers blood pressure by relaxing vascular smooth muscle [3]. * **Calcitonin Gene-Related Peptide (CGRP) (Option D):** One of the most powerful vasodilators in the body. It plays a significant role in the pathogenesis of migraines by causing vasodilation of intracranial blood vessels. **3. NEET-PG High-Yield Pearls:** * **Endothelin Antagonists:** **Bosentan** (non-selective $ET_A/ET_B$ antagonist) and **Ambrisentan** (selective $ET_A$ antagonist) are used in the treatment of **Pulmonary Arterial Hypertension (PAH)** [2], [3]. * **CGRP Antagonists:** Drugs like **Erenumab** (monoclonal antibody) and **Gepants** (e.g., Rimegepant) are used for migraine prophylaxis and treatment. * **ACE Inhibitors:** These drugs increase levels of Bradykinin (by preventing its breakdown), which contributes to both their antihypertensive effect and the common side effect of a **dry cough**.

Q: Which amongst the following endothelin is involved in myocardial infarction?

Endothelin 1. **Explanation:** **Endothelin-1 (ET-1)** is the correct answer because it is the most potent endogenous vasoconstrictor and the primary isoform produced by the vascular endothelium. In the context of **Myocardial Infarction (MI)**, ET-1 levels rise significantly in response to hypoxia and ischemia. It contributes to the pathophysiology of MI by causing intense coronary vasoconstriction, promoting inflammation, and stimulating the proliferation of vascular smooth muscle cells. Elevated plasma levels of ET-1 are often used as a prognostic marker for the severity of heart failure and the extent of myocardial damage following an infarct. **Analysis of Incorrect Options:** * **Endothelin-2 (ET-2):** While structurally similar to ET-1, it is primarily produced in the kidneys and intestine. It plays a role in ovulation and renal homeostasis but is not the dominant isoform involved in cardiac ischemic events. * **Endothelin-3 (ET-3):** This isoform is mainly found in the brain and gastrointestinal tract. It is crucial for the development of neural crest-derived cells (melanocytes and enteric neurons); mutations in ET-3 are associated with Waardenburg syndrome and Hirschsprung disease. * **Endothelin-4:** This is a distractor; there is no human endothelin isoform officially designated as ET-4 (though ET-4 is sometimes used to refer to a specific peptide in other species, it is not clinically relevant in human biochemistry). **High-Yield Clinical Pearls for NEET-PG:** * **Receptors:** ET-1 acts via two G-protein coupled receptors: **$ET_A$** (vasoconstriction) and **$ET_B$** (vasodilation via NO release). * **Clinical Application:** **Bosentan** is a dual endothelin receptor antagonist used in the treatment of Pulmonary Arterial Hypertension (PAH). * **Stimuli for Release:** ET-1 release is stimulated by Angiotensin II, ADH, thrombin, and shearing forces, while it is inhibited by Nitric Oxide (NO) and Prostacyclin.

Q: What is the cardiac cycle duration in seconds for a person with a heart rate of 75 beats per minute?

0.8. ### Explanation **1. Why Option B is Correct:** The cardiac cycle duration is inversely proportional to the heart rate. It represents the time taken for one complete heartbeat, including both systole and diastole. The mathematical formula to calculate the duration is: **Cardiac Cycle Duration (seconds) = 60 / Heart Rate (bpm)** For a heart rate of 75 bpm: $60 \div 75 = 0.8 \text{ seconds}$ In a standard 0.8s cycle, atrial systole lasts 0.1s, ventricular systole lasts 0.3s, and total diastole (quiescent period) lasts 0.4s. **2. Why Other Options are Incorrect:** * **Option A (0.4s):** This would correspond to a heart rate of 150 bpm ($60/0.4$). This is a state of significant tachycardia. * **Option C (1.0s):** This corresponds to a heart rate of 60 bpm ($60/1.0$), which is the lower limit of a normal resting heart rate. * **Option D (1.6s):** This corresponds to a heart rate of 37.5 bpm ($60/1.6$), indicating severe bradycardia (e.g., complete heart block). **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Inverse Relationship:** When the heart rate increases, the duration of the cardiac cycle decreases. * **Diastole is Vulnerable:** When the heart rate increases, the **diastolic phase shortens significantly more** than the systolic phase. Since coronary perfusion occurs primarily during diastole, extreme tachycardia can lead to myocardial ischemia. * **Formula for Systole:** A common rule of thumb is that ventricular systole occupies approximately 1/3 of the cycle, while diastole occupies 2/3 at resting rates. * **Atrial vs. Ventricular:** Remember that atrial and ventricular cycles overlap; they do not occur in a simple linear sequence of 0.1 + 0.3 + 0.4.

Q: A left ventricular pressure-volume loop is shown. During exercise within physiological limits, what is the effect on end-systolic volume?

Decreases. ***Decreases*** - During exercise, **sympathetic stimulation** increases myocardial contractility, shifting the **end-systolic pressure-volume relationship (ESPVR)** leftward and upward. - This enhanced contractility allows the heart to eject more blood, reducing **end-systolic volume** and increasing **stroke volume** and **ejection fraction**. *Increases* - End-systolic volume would increase if contractility decreased or if there was **heart failure**, not during normal physiological exercise. - Exercise actually enhances **cardiac performance** through increased contractility, leading to more complete ventricular emptying. *Remains unchanged* - End-systolic volume cannot remain constant during exercise as the heart must adapt to increased **metabolic demands**. - The **Frank-Starling mechanism** and **sympathetic activation** both work to optimize cardiac output, necessarily changing end-systolic volume. *First decreases then increases* - This pattern would suggest initial improvement followed by **cardiac decompensation**, which doesn't occur in physiological exercise. - Normal exercise maintains **enhanced contractility** throughout, consistently reducing end-systolic volume without subsequent deterioration.

Q: What is the action of Atrial Natriuretic Peptide (ANP)?

Induces bradycardia and hypotension. **Explanation:** Atrial Natriuretic Peptide (ANP) is a hormone released by the atrial myocytes in response to **atrial stretch** (increased preload/volume overload). Its primary physiological role is to decrease blood pressure and blood volume. **Why Option A is Correct:** ANP acts as a potent vasodilator and promotes natriuresis (sodium excretion) and diuresis (water excretion), which directly leads to **hypotension**. Interestingly, while most vasodilators cause reflex tachycardia, ANP inhibits the baroreceptor reflex and decreases sympathetic outflow while increasing vagal tone. This results in a paradoxical **bradycardia** (the Bezold-Jarisch-like effect), making "bradycardia and hypotension" the correct physiological profile. **Why Other Options are Incorrect:** * **Options B & C (Hypertension):** ANP is an antagonist to the Renin-Angiotensin-Aldosterone System (RAAS). It inhibits renin and aldosterone secretion, leading to a decrease in blood pressure, not an increase. * **Options B & D (Tachycardia):** Although hypotension usually triggers the baroreflex to increase heart rate, ANP specifically blunts this sympathetic response, leading to a lower heart rate (bradycardia) rather than tachycardia. **High-Yield NEET-PG Pearls:** * **Mechanism:** ANP acts via **membrane-bound Guanylyl Cyclase**, increasing intracellular **cGMP**. * **Kidney Effects:** It dilates afferent arterioles and constricts efferent arterioles, thereby **increasing GFR** while promoting sodium loss. * **Clinical Marker:** **BNP (Brain Natriuretic Peptide)**, secreted by ventricles, is a more stable clinical marker used to diagnose and monitor Heart Failure. * **Antagonist:** ANP is the "natural antagonist" to Aldosterone and Angiotensin II.

Q: Which statement is true regarding heart sounds?

The first heart sound has the maximum duration.. ### Explanation The heart sounds are discrete auditory events produced by the vibrations of the cardiac valves and blood flow. Understanding their physical characteristics is essential for clinical diagnosis. **Why Option B is Correct:** The **First Heart Sound (S1)** is produced by the closure of the Atrioventricular (AV) valves (Mitral and Tricuspid) at the onset of ventricular systole. Compared to the second heart sound (S2), S1 is characterized as being **longer in duration** (approx. 0.10–0.17 seconds), lower in pitch (frequency), and softer (the "Lubb" sound). Its longer duration is attributed to the relatively slower closure of the AV valves and the prolonged vibrations of the chordae tendineae and ventricular walls. **Analysis of Incorrect Options:** * **Option A:** S1 has a **lower frequency** (25–45 Hz) compared to S2 (50 Hz). S2 is higher-pitched and "snappier" (the "Dupp" sound). * **Option C:** S1 is due to the closure of **AV valves**, not semilunar valves. * **Option D:** S2 is due to the closure of **Semilunar valves** (Aortic and Pulmonary) at the onset of ventricular diastole. **High-Yield NEET-PG Pearls:** * **S1 Splitting:** Usually narrow and best heard at the tricuspid area; M1 (Mitral) precedes T1 (Tricuspid). * **S2 Splitting:** Physiological splitting increases during **inspiration** (increased venous return to the right heart delays P2). * **S3 (Ventricular Gallop):** Occurs during the rapid filling phase; normal in children/athletes but indicates **Heart Failure** in adults. * **S4 (Atrial Gallop):** Occurs during atrial contraction; always pathological, indicating a **stiff ventricle** (e.g., LV hypertrophy).

Q: The following ECG findings are seen in hypokalemia:

Increased PR interval with ST depression. **Explanation:** Hypokalemia (low serum potassium) significantly affects the electrical activity of the heart by altering the resting membrane potential and prolonging the repolarization phase. **1. Why Option A is Correct:** In hypokalemia, the resting membrane potential becomes more negative (hyperpolarized), which slows down conduction through the AV node, leading to an **increased PR interval**. Furthermore, low potassium levels affect the repolarization phase (Phase 3), causing **ST-segment depression**, flattening or inversion of T waves, and the appearance of prominent **U waves**. **2. Why the Other Options are Incorrect:** * **Option B:** Peaked T waves are the hallmark of **Hyperkalemia**, not hypokalemia. In hyperkalemia, the PR interval may also increase, but the T wave morphology is the distinguishing factor. * **Option C:** While T wave inversion occurs in hypokalemia, the "prolonged QT interval" is often a misinterpretation. In hypokalemia, the T wave flattens and merges with the U wave, creating a **"QU interval"** that appears long. True QT prolongation is more characteristic of hypocalcemia. * **Option D:** Decreased QT interval is typically seen in **Hypercalcemia** or Digitalis effect, not hypokalemia. **High-Yield Clinical Pearls for NEET-PG:** * **ECG Sequence in Hypokalemia:** T wave flattening → ST depression → Prominent U waves (best seen in V2-V4) → Apparent prolongation of QT (actually QU interval). * **U Wave:** It is the most characteristic finding. It represents the delayed repolarization of Purkinje fibers. * **Danger:** Severe hypokalemia can predispose patients to **Torsades de Pointes** and ventricular arrhythmias. * **Mnemonic:** "Hypo-K has a low T (flat), a low ST (depression), and a big U."

Question 1

All of the following peptides produce vasodilation in most vascular beds EXCEPT?

Accepted Answer

Endothelin

Answer

Bradykinin

Answer

Vasoactive intestinal peptide

Answer

Calcitonin gene-related peptide

Question 2

Which amongst the following endothelin is involved in myocardial infarction?

Accepted Answer

Endothelin 1

Answer

Endothelin 2

Answer

Endothelin 3

Answer

Endothelin 4

Question 3

What is the cardiac cycle duration in seconds for a person with a heart rate of 75 beats per minute?

Accepted Answer

0.8

Answer

0.4

Answer

1.0

Answer

1.6

Question 4

A left ventricular pressure-volume loop is shown. During exercise within physiological limits, what is the effect on end-systolic volume?

Accepted Answer

Decreases

Answer

Increases

Answer

Remains unchanged

Answer

First decreases then increases

Question 5

What is the action of Atrial Natriuretic Peptide (ANP)?

Accepted Answer

Induces bradycardia and hypotension

Answer

Induces tachycardia and hypertension

Answer

Induces bradycardia and hypertension

Answer

Induces tachycardia and hypotension

Question 6

How does chronic hypertension affect the range of arterial pressure over which the cerebral circulation can maintain relatively constant blood flow?

Accepted Answer

The entire range of regulation shifts to higher pressures

Answer

Very little change occurs

Answer

The vasculature primarily adapts to higher arterial pressure

Answer

The vasculature primarily loses regulation at low arterial pressure

Question 7

Which statement is true regarding heart sounds?

Accepted Answer

The first heart sound has the maximum duration.

Answer

The first heart sound has the maximum frequency.

Answer

The first heart sound is due to the closure of semilunar valves.

Answer

The second heart sound is due to the closure of atrioventricular valves.

Question 8

Blood flow in the splanchnic area during exercise is decreased due to which of the following mechanisms?

Accepted Answer

Venoconstriction with decreased blood flow

Answer

Venodilation with decreased blood flow

Answer

Venodilation with increased blood flow

Answer

Venodilation with normal blood flow

Question 9

The following ECG findings are seen in hypokalemia:

Accepted Answer

Increased PR interval with ST depression

Answer

Increased PR interval with peaked T wave

Answer

Prolonged QT interval with T wave inversion

Answer

Decreased QT interval with ST depression

Question 10

Cardiac muscle is able to function as a syncytium because of the structural presence of which of the following?

Accepted Answer

Gap junctions

Answer

Branching fibres

Answer

Intercalated discs

Answer

Protoplasmic bridges between cells

Cardiovascular System — MCQs

Cardiovascular System — MCQs

On this page

Practice by Chapter

Want unlimited practice?